Literature DB >> 1312670

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions.

A G Elefanty1, S Cory.   

Abstract

Irradiated mice reconstituted with bone marrow cells infected with a retrovirus carrying the bcr-abl oncogene of human chronic myeloid leukemia are subject to a range of neoplastic hematopoietic diseases, both myeloid and lymphoid. Comparison of DBA/2 and C57BL/6 mice has revealed a marked strain difference in susceptibility to the various tumor types. The present study, performed with BALB/c mice, indicates that the kinetics and nature of the induced disease can be modulated by the infection procedure, as well as the genetic background, and that retroviral regulatory sequences may influence the outcome. A distinctive clonal myeloproliferative disorder, somewhat akin to chronic myeloid leukemia but with prominent erythroid and mast cell components, as well as granulocytic excess, was characterized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312670      PMCID: PMC369619          DOI: 10.1128/mcb.12.4.1755-1763.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.

Authors:  W Y Langdon; A W Harris; S Cory; J M Adams
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

Review 2.  Activation of the abl oncogene in murine and human leukemias.

Authors:  J B Konopka; O N Witte
Journal:  Biochim Biophys Acta       Date:  1985-11-12

3.  A bcr-v-abl oncogene induces lymphomas in transgenic mice.

Authors:  I K Hariharan; A W Harris; M Crawford; H Abud; E Webb; S Cory; J M Adams
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

4.  Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function.

Authors:  P A Scherle; K Dorshkind; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Authors:  M A Kelliher; J McLaughlin; O N Witte; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.

Authors:  C Stocking; R Kollek; U Bergholz; W Ostertag
Journal:  Virology       Date:  1986-08       Impact factor: 3.616

7.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

8.  Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses.

Authors:  D D Bowtell; G R Johnson; A Kelso; S Cory
Journal:  Mol Biol Med       Date:  1987-08

9.  In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

10.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

View more
  7 in total

1.  The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl.

Authors:  X Zhang; R Subrahmanyam; R Wong; A W Gross; R Ren
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy.

Authors:  A W Gross; X Zhang; R Ren
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 3.  Models of chronic myeloid leukemia.

Authors:  R A Van Etten
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

4.  Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.

Authors:  J Schwaller; J Frantsve; J Aster; I R Williams; M H Tomasson; T S Ross; P Peeters; L Van Rompaey; R A Van Etten; R Ilaria; P Marynen; D G Gilliland
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

5.  BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.

Authors:  S S Clark; E Chen; M Fizzotti; O N Witte; V Malkovska
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.

Authors:  M L Gishizky; J Johnson-White; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.